{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-25-009253","form_type":"8-K","ticker":"AMRX","cik":"0001723128","company_name":"Amneal Pharmaceuticals, Inc.","filed_at":"2025-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.803376+00:00","generated_at":"2026-05-18T02:26:11.079140+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Amneal prices $600M 6.875% senior secured notes due 2032, upsizes term loan to $2.1B","bullets":["$600M notes priced at par with 6.875% coupon, due 2032; downsized from $750M due to term loan increase.","New term B loans upsized to $2.1B from $1.8B, seven-year maturity.","Proceeds to refinance existing term B loans in full and repay ABL facility.","Closing expected August 1, 2025, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-25-009253","json":"https://secwatch.observer/filing/0000950103-25-009253.json","markdown":"https://secwatch.observer/filing/0000950103-25-009253.md","text":"https://secwatch.observer/filing/0000950103-25-009253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723128/000095010325009253/0000950103-25-009253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723128/000095010325009253/dp232033_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T02:26:11.079140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}